The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

In a large analysis presented at ASH's annual meeting, researchers reported that patients' MRD status after intensive chemo can predict their survival.

Scientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has ...

Scientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding shareholder value over time. See why CTKB is a Buy.

Thermo Fisher Scientific has introduced Invitrogen™ UltraComp eBeads™ Spectral Unmixing Beads to improve accuracy in spectral and conventional flow cytometry. These beads help researchers more ...

FHFA Director Bill Pulte should direct the agency to examine credit scoring models based on cash flow as a complement to existing systems, writes Martin Kleinbard, of Granular Fintech. In 1995, the ...

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial Invivoscribe Inc., a ...

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company ...

Former WeWork CEO Adam Neumann has raised over $100 million in capital for his proptech startup, Flow, in a round that values that company at about $2.5 billion, Bloomberg reported on Thursday. Citing ...